Trials / Completed
CompletedNCT03330392
Evaluation of Efficacy and Safety of AGP on Immune Enhancement
An 8 Week, Randomized, Double-blind, Placebo-controlled Clinical Trial of AGP on Immune Enhancing Effects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Chonbuk National University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The researchers investigated the immune enhancing effects of AGP for Korean participants.
Detailed description
The aim of the study is to investigate the effects of AGP on immune enhancement based on 8 week, randomized, double-blind, placebo-controlled clinical trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | AGP | take two tablets per day (500 mg/day) for 8 weeks |
| DIETARY_SUPPLEMENT | Placebo | take two tablets per day (500 mg/day) for 8 weeks |
Timeline
- Start date
- 2017-07-01
- Primary completion
- 2017-09-07
- Completion
- 2017-10-27
- First posted
- 2017-11-06
- Last updated
- 2017-11-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03330392. Inclusion in this directory is not an endorsement.